BioHarvest Sciences Inc. - Common Stock (BHST)

1.9100
+0.00 (0.00%)
NASDAQ· Last Trade: Sep 1st, 6:16 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Q3 Virtual Investor Summit Presentations Now Available On Demand
NEW YORK, NY / ACCESS Newswire / August 31, 2026 / Investor Summit Group is pleased to announce that presentations from its Q3 Virtual Conference are now available on demand. Investors who missed the live event can catch up at their convenience.
By Investor Summit Group · Via ACCESS Newswire · August 31, 2026
Investor Summit | MicroCap Opportunities to Watch - August 26
NEW YORK CITY, NY / ACCESS Newswire / August 24, 2026 / The Investor Summit today announced the lineup of public companies scheduled to present at its upcoming Virtual August 26, 2026 event.
By Investor Summit Group · Via ACCESS Newswire · August 24, 2026
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
Secured first ever CDMO Manufacturing Agreement supporting planned 20-ton commercial production program over two years for rare botanical fragrance,...
Via Newsfile · August 11, 2026
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
Exclusive agreement through 2027 and 2028 is estimated to generate $20-$30 million in revenuePositions BioHarvest in sustainable rare luxury...
Via Newsfile · August 11, 2026
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 29, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · July 29, 2026
BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 28, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the...
Via Newsfile · July 28, 2026
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 15, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · July 15, 2026
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 13, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · July 13, 2026
Q2 Investor Summit Virtual Live Wednesday June 24
NEW YORK, NY / ACCESS Newswire / June 23, 2026 / The Investor Summit today announced the lineup of public companies scheduled to present at its upcoming Virtual June 24-25, 2026 event.
By Investor Summit Group · Via ACCESS Newswire · June 23, 2026
BioHarvest Sciences to Present at the 2026 BIO International Convention
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · June 18, 2026
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 18, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a...
Via Newsfile · May 18, 2026
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Quarterly revenue up 8% year over year; Annual revenue guidance range remains at $42-$48 million CDMO fragrance and Saffron...
Via Newsfile · May 14, 2026
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · May 13, 2026
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
- CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production...
Via Newsfile · May 13, 2026
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
Source plant is widely regarded as one of the most valuable fragrance raw materials in the worldStage 2 contract follows...
Via Newsfile · May 12, 2026
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · April 30, 2026
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role...
Via Newsfile · April 29, 2026
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
FY2025 Revenues were $34.5 million, up 37% vs previous year.The VINIA brand has achieved the No.1 resveratrol polyphenol...
Via Newsfile · March 31, 2026
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 31, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Via Newsfile · March 31, 2026
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 26, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the...
Via Newsfile · March 26, 2026
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or...
Via Newsfile · March 17, 2026
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 5, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the...
Via Newsfile · March 5, 2026
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a...
Via Newsfile · March 3, 2026
BioHarvest Sciences Issues Year End Shareholder Letter
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 7, 2026) - BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0)...
Via Newsfile · January 7, 2026
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 18, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or...
Via Newsfile · December 18, 2025